Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001628280-26-040215

Options or other derivatives

  • Chief Financial Officer acquired 193,688 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kelly John Alexander Chief Financial Officer 2026-06-01 Grant or award · Restricted Stock Units +193,688 193,688 D
Loading xslF345X06/wk-form4_1780517141.xml…